Mechanistically, we demonstrated that treatment with Tβ4 in the MI model results in significant improvement of cardiac function by suppressing NF-κB and collagens synthesis, suggesting a potential use of Tβ4 for therapeutic intervention. The gene discussed is NFKB1; the disease is myocardial infarction.